Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
54,731,500
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
31,028,457
-
Shares change
-
+1,535,414
-
Total reported value, excl. options
-
$480,277,396
-
Value change
-
+$31,148,764
-
Put/Call ratio
-
3.54%
-
Number of buys
-
58
-
Number of sells
-
-28
-
Price
-
$15.48
Significant Holders of MARINUS PHARMACEUTICALS, INC. - COMMON STOCK (MRNS) as of Q1 2021
106 filings reported holding MRNS - MARINUS PHARMACEUTICALS, INC. - COMMON STOCK as of Q1 2021.
MARINUS PHARMACEUTICALS, INC. - COMMON STOCK (MRNS) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31,028,457 shares
of 54,731,500 outstanding shares and own 56.69% of the company stock.
Largest 10 shareholders include Lion Point Capital, LP (3,618,334 shares), Avoro Capital Advisors LLC (3,235,000 shares), BlackRock Inc. (2,726,638 shares), VR Adviser, LLC (2,641,809 shares), BOXER CAPITAL, LLC (2,400,000 shares), 683 Capital Management, LLC (1,893,400 shares), SUVRETTA CAPITAL MANAGEMENT, LLC (1,826,445 shares), VANGUARD GROUP INC (1,702,989 shares), ADAGE CAPITAL PARTNERS GP, L.L.C. (1,462,500 shares), and Bain Capital Life Sciences Investors, LLC (1,431,058 shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.